Trifluoperazine Tablets IP 5 mg Manufacturer

Trifluoperazine Tablets IP 5 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Trifluoperazine Tablets IP 5 mg Manufacturer product packaging

Trifluoperazine Tablets IP 5 mg | Manufacturer

Product image for Trifluoperazine Tablets IP 5 mg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameTrifluoperazine
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaIP
Product TypeTablet
CategoryAntipsychotic drugs
SubcategoryAntipsychotic drugs
Active IngredientTrifluoperazine
Strength5 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntipsychotic drugs

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Trifluoperazine Tablets IP 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Acute and maintenance treatment of schizophrenia and related psychotic disorders. 2. Bipolar I disorder mania, mood stabilization, and severe behavioral agitation.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Trifluoperazine Tablets IP 5 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameTrifluoperazine
CompositionTrifluoperazine
Strength5 mg
CategoryAntipsychotic drugs
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Trifluoperazine Tablets IP 5 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Trifluoperazine Tablets IP 5 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Trifluoperazine Tablets IP 5 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally once or twice daily, with or without food. Titrate gradually from a low initial dose under close psychiatric supervision. Do not discontinue therapy abruptly.
Side EffectsCommon: Somnolence, sedation, dry mouth, weight gain, constipation, mild dizziness. Uncommon: Extrapyramidal symptoms, orthostatic hypotension, akathisia, elevated prolactin. Rare: Neuroleptic malignant syndrome, tardive dyskinesia, agranulocytosis (with clozapine).
Warnings and PrecautionsMetabolic Monitoring: Regularly check fasting blood glucose, lipid profiles, and body weight. Hematologic & ECG Monitoring: Periodic complete blood counts and ECGs are indicated during chronic therapy. Sedation & Driving: Avoid driving or operating machinery until individual tolerance is established.
Contraindications1. Hypersensitivity to Trifluoperazine or related psychotropic derivatives.
2. Severe central nervous system depression, comatose states, or severe bone marrow suppression.
3. Uncontrolled epilepsy or history of severe blood dyscrasias.
Drug Interactions1. CNS Depressants & Alcohol: Potentiated sedation, psychomotor slowing, and respiratory depression.
2. Antihypertensives: Synergistic orthostatic hypotensive effects.
3. CYP Enzymes: Inhibitors (fluoxetine, ketoconazole) increase antipsychotic levels; inducers decrease efficacy.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Trifluoperazine Tablets IP 5 mg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Trifluoperazine Tablets IP 5 mg?The source specification is IP; confirm the required standard before contracting.
What quality tests are applicable for Trifluoperazine Tablets IP 5 mg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Trifluoperazine Tablets IP 5 mg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Trifluoperazine Tablets IP 5 mg?Provide forecast volume, target market, strength and packaging requirements.

Product Tags

Trifluoperazine Tablets IP 5 mg ManufacturerTrifluoperazine 5 mgContract ManufacturingOEM & Quality ControlHealthy Life Pharma Pvt. Ltd.

Product Hashtags

#Trifluoperazine#Manufacturer#PharmaB2B

Related Products

Latest Posts